Your browser doesn't support javascript.
loading
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Xie, Tianhong; Lu, Shuaiyao; He, Zhanlong; Liu, Hongqi; Wang, Junbin; Tang, Cong; Yang, Ting; Yu, Wenhai; Li, Hua; Yang, Yun; Yang, Hao; Yue, Lei; Zhou, Yanan; Yang, Fengmei; Luo, Zhiwu; Li, Yanyan; Xiang, Hong; Zhao, Yuan; Wang, Jie; Wang, Haixuan; Long, Runxiang; Kuang, Dexuan; Tan, Wenjie; Peng, Xiaozhong; Li, Qihan; Xie, Zhongping.
Afiliação
  • Xie T; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Lu S; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • He Z; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Liu H; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Wang J; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Tang C; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yang T; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yu W; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Li H; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yang Y; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yang H; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yue L; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Zhou Y; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Yang F; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Luo Z; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Li Y; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Xiang H; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Zhao Y; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Wang J; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Wang H; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Long R; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Kuang D; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.
  • Tan W; The NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, 102206, Beijing, China. tanwj@ivdc.chinacdc.cn.
  • Peng X; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. pengxiaozhong@pumc.edu.cn.
  • Li Q; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. imbcams.lq@gmail.com.
  • Xie Z; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. xzp@imbcams.com.cn.
Signal Transduct Target Ther ; 7(1): 61, 2022 02 25.
Article em En | MEDLINE | ID: mdl-35217639
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas de Produtos Inativados / Vacinação / Anticorpos Neutralizantes / Proteção Cruzada / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas de Produtos Inativados / Vacinação / Anticorpos Neutralizantes / Proteção Cruzada / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article